Pathology-validated PET image data sets and their role in PET segmentation

Abstract

Positron emission tomography (PET)/computed tomography has recently been finding broader application for the diagnosis, treatment and therapy assessment of malignant disease. Accurate definition of the tumor border is extremely important for the success of localized tumor therapies. PET promises to provide the metabolically active tumor volume and, at present, it is used for target definition in a variety of tumors. This process is, however, subject to uncertainties of different origin. Resolving these uncertainties is challenging, since validating PET images and segmentation contours against tumor pathology is experimentally difficult. In addition to accurate lesion contouring, this challenges validation of PET tracers and investigations of tumor functional heterogeneity. In this paper, we briefly review the present studies providing PET image data sets with pathology validation. We focus on the specimen handling techniques aimed at achieving higher geometrical accuracy of the pathology-derived "ground truth". We also summarize the main findings obtained for the PET segmentation techniques which have been tested with the help of these data sets. Finally, we provide a critical summary of the current state of the art in pathological validation of PET images and briefly discuss future possibilities in this direction. © 2014 Italian Association of Nuclear Medicine and Molecular Imaging.